We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...
Centers for Disease Control and Prevention (CDC) data shows an alarming increase in obesity among the United States (US) population, from 30.5% in 2000 to 42.4% in 2018. The combination of overweight ...
Lipoprotein(a) (Lp[a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo[a]), a plasminogen-like protein that confers ...
The following are key points to remember from a state-of-the-art review on the benefits and drawbacks of vegetarian and vegan diets: ...
The following are key points to remember from the American Heart Association/American Stroke Association (AHA/ASA) guideline for the prevention of stroke in patients with stroke and transient ischemic ...
Physicians hold the ability to change the narrative of clinical trials in the short- and long-term to better represent patient populations who are diverse in sex, gender, race, and ethnicity to ...
Consumption of ultra-processed foods, such as sugar-sweetened beverages, potato chips and packaged cookies, may be associated with adverse health outcomes, according to research being presented at the ...
Sorry to break your heart. You might find something similar through our search. Please try again.
As smartphones continue to be an inherent part of life and grow as a primary source of entertainment—particularly among young people—it leads to a decrease in physical activity. In a recent study ...
The following are key perspectives from the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AF): ...
The U.S. is first among all industrialized nations by to have one of the most high-tech and advanced care repertoire for cardiovascular disease in the world. A significant amount of money has been and ...
New USPSTF Recommendation on Aspirin in CVD: No For Primary Prevention, Yes For Secondary Prevention
New guidance from the U.S. Preventive Service Task Force (USPSTF) recommends against initiating the use of low-dose aspirin in patients over 60 years of age for primary prevention of atherosclerotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results